Vaccination against COVID-19

We would like to inform that each and every patient, regardless of whether that person has a Medicover subsc.ription or not, can choose a Medicover facility as a vaccination place. Both the vaccine and the vaccination/qualification visit are free for all patients. The vaccination process for patients follows the order of immunization announced by the Government.

We would like to remind that the latest information on vaccinations under the National SARS-CoV-2 Vaccination Program is also available on the dedicated website: gov.pl/szczepimysie.

 

 

Why does it make sense to get vaccinated against COVID-19?

Is the vaccine safe?

When can you get vaccinated?

Medicover Medical Centres partcipatng in the vaccinaton programme (PDF>>)

Vaccination against COVID-19 question and answers



 

Vaccination against COVID-19 question and answers

  1. How many doses of vaccine are needed to achieve immunity?
  2. When will my immunity develop after the vaccination?
  3. Will Medicover carry out mobile vaccinations – at the patient’s address?
  4. I have a chronic illness. Can a Medicover doctor issue an e-Referral for my vaccination?
  5. Is a history of COVID-19 a contraindication to vaccination?
  6. As a vaccinated person, can I "infect" others, can I transmit the virus?
  7. Should vaccinated persons still wear face masks?
  8. Who cannot get vaccinated?
  9. Why does it make sense to get vaccinated against COVID-19?
  10. When can you get vaccinated?
  11. Who will be first in line to get vaccinated?
  12. Can the vaccine cause the coronavirus infection?
  13. Can the vaccine weaken my immune system and then I will fall ill, for example, with flu?
  14. How long does it take for the vaccine to become active? Is it true that I can still be infected with COVID-19 for two weeks?
  15. Will patients have to wait in the waiting room for a certain amount of time just after the vaccination?
  16. Is the vaccination safe for children?
  17. If there are side effects such as muscle pain and fever after the vaccination, how do I know that this is not a COVID-19 infection?
  18. If I am currently undergoing asymptomatic COVID-19, will the vaccine make me feel worse?
  19. Does the flu vaccine protects against COVID-19?
  20. Are vaccines used to implant microchips?
  21. Will the vaccine give me lifelong immunity?
  22. Can I move around without a face mask after the vaccination?
  23. Will the vaccination against COVID-19 be part of Medicover packages?
  24. What will be the price of the vaccination against COVID-19 at Medicover?
  25. How can I sign up for the COVID-19 vaccination at Medicover?
  26. When can I get vaccinated against COVID-19?
  27. What are the side effects of the COVID-19 vaccination?
  28. Can I choose the vaccine I will be vaccinated with?
  29. Is the vaccine safe?
  30. Do I have to get vaccinated?
  31. If the vaccination causes any serious complications, will I get any compensation?
  32. How did it happen that the vaccine was developed so quickly?
  33. Will a doctor examine me before the vaccination?
  34. Do any tests need to be done before the vaccination?
  35. What is the vaccine administration like?
  36. Is a referral required for the vaccination?
  37. Will vaccinations against COVID-19 be available at Medicover?

 


1. How many doses of vaccine are needed to achieve immunity?

For the Comirnaty and COVID-19 Vaccine Moderna preparations, the second dose is administered about 6 weeks (no longer than 42 days) after the first one. The second dose of COVID-19 Vaccine AstraZeneca is given about 12 weeks (no longer than 84 days) from the first dose. One dose is enough for the COVID-19 Vaccine Janssen vaccine.

After each vaccination, your body needs some time to acquire post-vaccination immunity. The COVID-19 vaccines listed above may not provide protection until one week (Comirnaty) or two weeks (COVID-19 Vaccine Moderna) or 15 days (COVID-19 Vaccine AstraZeneca) after the administration of the second dose. COVID-19 Vaccine Janssen may provide protection approximately 14 days after vaccination (one dose only).


2. When will my immunity develop after the vaccination?

For the Comirnaty preparation, the vaccine may not provide full protection until at least 7 days after receiving the second dose, and at least 14 days for COVID-19 Vaccine Moderna and COVID-19 Vaccine Janssen.

The efficacy of Comirnaty, assessed as the incidence of COVID-19 at least 7 days after receiving the second dose of vaccine, was determined to be 95%. The efficacy was independent of age, sex, race, ethnic group, obesity and other existing health conditions. Between the first and the second doses, the vaccine efficacy was determined to be 52%. For COVID-19 Vaccine Moderna, the efficacy to prevent COVID-19 within 14 days after the second dose was 94.1%. For COVID-19 Vaccine AstraZeneca, partial protection starts about 3 weeks after the first injection and lasts for up to 12 weeks. Vaccine efficacy in reducing the incidence of disease was estimated to be approximately 60% from day 15 after taking the second dose.

For the AstraZeneca COVID-19 Vaccine, the efficacy in preventing COVID-19 ≥15 days after the second dose was approximately 60%.

For the Janssen COVID-19 Vaccine, the efficacy in preventing COVID-19 was assessed 14 days after vaccination and the results are as follows:

  • 9% in the analysis of all participants,
  • 2% in people aged 18-64,
  • 4% in people aged 65 and more,
  • as much as 100% in people aged 75 and over.

In turn, 28 days after vaccination, it was 66.1% in the analysis of all participants, 65.1% in those aged 18-64, and 74% in those aged 65 and over.

Efficacy against severe COVID-19 was 76.7%, assessed 14 days after vaccination and 85.4%, 28 days after vaccination.

The currently available vaccines may not provide protection to all vaccinated individuals.

The duration of protection provided by the vaccines is unknown as this is still being determined in ongoing clinical trials.


3. Will Medicover carry out mobile vaccinations – at the patient’s address? 

The vaccination programme includes mobile vaccination teams that vaccinate patients at their residence addresses. The mobile vaccinations are intended for persons who are not able to visit a vaccination centre on their own due to a disability.

The dates in the Medicover vaccination schedule available so far refer to vaccinations at healthcare centres – the vaccinations at these dates take place only at medical facilities. Medicover is still working on making mobile schedules available and on organising visits to patients in such a way as to minimise the risk of wasting vaccine preparations.

Therefore, please come to your registered appointment at our centre. If this is not possible, please cancel your visit and wait for the opportunity to arrange a mobile appointment.

At the same time, we recommend to contact your municipality or town council office. By the order of the government, the authorities shall provide support in transporting patients to vaccination facilities.


4. I have a chronic illness. Can a Medicover doctor issue an e-Referral for my vaccination? 

The Ministry of Health has not yet issued a detailed regulation about how the e-Referrals for patients with chronic diseases shall be issued. Consequently, Medicover doctors do not issue such e-Referrals yet.


5. Is a history of COVID-19 a contraindication to vaccination?

No, according to the US Center for Disease Prevention and Control (CDC), the vaccine can be safely administered to people who have a history of COVID-19.

According to the regulation of 11 March 2021, people who have had COVID-19 can be vaccinated against COVID-19 not earlier than 3 months after obtaining a positive test for the presence of the SARS-CoV-2 virus.

Since people with SARS-CoV-2 infection have already acquired immunity, and relapses of COVID-19 within 90 days of the original infection are rare, vaccination of convalescents may be postponed even until then.

This does not apply to people who:

  • are on dialysis for chronic renal failure,
  • are undergoing cancer treatment with chemotherapy or radiotherapy conducted after 31 December 2019,
  • are under chronic mechanical ventilation,
  • have had cell, tissue and organ transplants and underwent immunosuppressive therapy,
  • have been diagnosed with cancer and qualified for chemotherapy or radiotherapy treatment, but have not started treatment yet,
  • are waiting for a transplant.

Vaccinating patients with an ongoing SARS-CoV-2 infection should be postponed.

 


6. As a vaccinated person, can I "infect" others, can I transmit the virus?

Vaccination protects against disease, but does not exclude transmission of the virus to unvaccinated persons. A clinical trial looked at the effect of vaccination in preventing symptomatic COVID-19, but not the SARS-CoV-2 infection. A vaccinated person can become infected after contact with a sick person, and although they will not develop the disease, they can infect others. It is not yet known whether vaccines also protect against the spread of the virus.


7. Should vaccinated persons still wear face masks?

Experts recommend that the vaccinated individuals should continue to cover their mouths and noses, maintain the recommended social distance, avoid gatherings, and wash or disinfect their hands frequently. The vaccination protects against the disease, but does not rule out transmission of the virus and infecting unvaccinated people. It is not yet known how vaccines are going to stop the spread of SARS-CoV-2 infection, so every available means of limiting the range of this pandemic should be used. Information on policies for vaccinated persons should be available at government websites.


8. Who cannot get vaccinated?

Hypersensitivity to the active substance or to any of the substances included in the vaccine is an absolute contraindication to vaccination, including in individuals who have experienced an anaphylactic reaction after the first dose of COVID-19 vaccine or a severe allergic reaction to the active substance or another vaccine component. Before vaccination, please inform the doctor if you have ever had a severe allergic reaction to any medication, vaccine or food.

Vaccination is not recommended due to limited clinical data in the following group:

  • children and teenagers up to the age of 16 (clinical studies have been conducted with the participation of persons aged 16 and over).

Due to limited data, the administration of COVID-19 vaccine in the following groups depends on the individual patient's decision and doctor’s opinion:

  • pregnant women and women planning to become pregnant - limited data are available; hence, the vaccination should only be considered if potential benefits outweigh any risk to the mother and the baby, e.g. in persons at risk of SARS-CoV-2 infection (e.g. active medical personnel) or severe COVID-19 (e.g. obesity, diabetes),
  • breastfeeding women - it is not known whether the vaccine passes into breast milk. There is no need to interrupt or avoid initiation of breastfeeding in women who have received a COVID-19 vaccine.

The vaccine has been tested on a group of over 43,000 individuals aged 16-65. In certain patient groups, its safety has not been tested. Therefore, vaccination is not recommended for:

  • children and youths under 16 years of age;
  • pregnant women and women who plan to get pregnant (they should not get pregnant for at least two months after taking a second dose of the vaccine);
  • breastfeeding women;
  • persons who receive anticoagulation treatment or persons with a clotting disorder, unless the potential benefits clearly outweigh the risk of administration of the vaccine;
  • persons who have ever had a serious allergic reaction to medications, vaccines or food. Before the vaccination, the doctor should be informed about any severe allergic reaction (anaphylactic shock) in the past.

During the qualification for the vaccination, inform the doctor if you:

  • suffer from any allergies,
  • have a fever,
  • have a blood clotting disorder and take anticoagulants,
  • have a reduced immunity or take any medication that affects your immune system,
  • are pregnant (or plan to get pregnant),
  • are breastfeeding,
  • have already been vaccinated with another vaccine against COVID-19.

Temporary contraindications to vaccination are as follows:

  • current or recent SARS-CoV-2 infection (until recovery) – this is to avoid the misallocation of any new symptom or progression of symptoms to the vaccine. As some people with COVID-19 may experience deterioration up to 2 weeks after infection, the vaccination should be postponed until recovery and at least 4 weeks after the onset of symptoms or 4 weeks after the first positive PCR test in case of asymptomatic carriers;
  • acute, severe infection with an accompanying fever – until the symptoms of infection disappear.

There is no contraindication for vaccinating individuals with immune disorders or receiving immunosuppressive treatment – but they may have a reduced immune response. The final decision on whether such a person can be vaccinated will be made by a doctor who qualifies for the vaccination.

Special care must be taken in case of patients with clotting disorders and patients taking anticoagulants. The doctor needs to be informed about any history of clotting disorder and about taking any medications for this condition. After the vaccination, some bleeding or haematoma may occur.

Vaccination of recovered patients

Studies to date have not confirmed any concerns about the safety of vaccinating people with a history of COVID-19 infection or with detectable COVID-19 antibodies. Consequently, the recovered patients should also be vaccinated. This is because it is not yet known how long the antibodies produced in response to the natural infection persist and whether the vaccination provides better protection. It is supposed that if the antibodies have already been produced as a result of a natural infection, getting infected with COVID-19 will activate the immune system.

Post-vaccination side effects

The majority of side effects are mild and should not last longer than a week. These side effects include, for instance:

  • short-term mild to moderate pain at the site of vaccination,
  • tiredness,
  • headache,
  • muscle pains,
  • shivers,
  • joint pains,
  • fever
  • redness or swelling at the vaccination site,
  • nausea,
  • poor physical state,
  • lymph node enlargement.

The safety of the vaccine was tested two months after the second dose was administered. However, observations of adverse reactions will continue to be made – as with any other medicinal product.


9. Why does it make sense to get vaccinated against COVID-19?

The benefits of the vaccination:

  • Taking Comirnata vaccine and COVID-19 Vaccine Moderna protects you in 95% against COVID-19 and serious complications of infection. The effectiveness of COVID-19 Vaccine AstraZeneca in protecting against COVID-19 has been estimated at approximately 60%.
    Getting vaccinated can help prevent the severe course of COVID-19 even if you get the disease.
    There was no person with a severe course of COVID-19 in the group receiving COVID-19 Vaccine AstraZeneca and COVID-19 Vaccine Moderna. There are no such data reported for Comirnata vaccine.
  • The vaccination helps the body to develop resistance to the virus that causes COVID-19 without first getting sick.
  • You will protect others – family and friends, especially all persons with an increased risk of
    a serious disease caused by COVID-19.
  • You will help to reduce the spread of the pandemic. Wearing masks and keeping the social distance helps to reduce the risk of exposure to the virus or spreading it to others, but these measures are not enough. If 50% of the population gets vaccinated, the spread of coronavirus will be significantly reduced. And by reducing the pandemic, it will be possible to slowly lift the restrictions and return to normal life.
  • Your example can encourage others - your family or friends.
  • Vaccinated people may skip quarantine.
  • Vaccinated people will not be counted towards the limit of five person for home events.
  • Vaccinated people can freely participate in rehabilitation.
  • Vaccinated people will not have to present a negative coronavirus test result when applying for admission to treatment or nursing facilities, social welfare home, inpatient hospice or palliative medicine unit.

Vaccination procedure.


10. When can you get vaccinated?

According to the details published at https://www.gov.pl/web/szczepimysie, the vaccinations in Poland started on 27 December 2020. It will probably be on January 15th that the registration for the phase one vaccinations (within the national programme of vaccinations against COVID-19) will begin.

Vaccinations schedule.

In addition, registration for COVID-19 vaccinations for individuals aged 40-59 who have confirmed their interest in the vaccination at the beginning of the year via the online form at https://szczepimysie.pacjent.gov.pl started on 01 April 2021.

These individuals already have e-referrals issued on their Online Patient Account and can make an appointment for vaccinations:

  • individuals aged 40-49: for May;
  • individuals aged 50-59: for the first available date.

11. Who will be first in line to get vaccinated?

The first doses (the so-called ‘zero stage’) will be made ready for the individuals who are most vulnerable to infection:

  • health care professionals (including those who carry out individual practice);
  • social welfare homes staff as well as municipal social welfare centres staff;
  • support and administrative staff at medical facilities, including sanitary and epidemiological stations,
  • parents of preterm babies hospitalised at the Neonatal Intensive Care Unit.

Vaccinations for medical and non-medical staff in stage zero will be arranged and carried out by central (node) hospitals located in each voivodship. The list of these hospitals is available at https://www.gov.pl/web/szczepimysie/szczepienia-personelu-placowek-medycznych

Dosage and administration of the vaccine

The vaccine is administered intramuscularly – to the upper arm muscle, in a series of two doses at an interval of 21 days. Protection against infection is observed 7 days after the second dose.


12. Can the vaccine cause the coronavirus infection?

No, because available vaccines contains only genetic information (mRNA) about the structure of a single SARS-CoV-2 virus protein. After the vaccination, the body "reads" this information and, on its basis, starts to produce antibodies. The information itself (mRNA) is not capable of causing an infection.


13. Can the vaccine weaken my immune system and then I will fall ill, for example, with flu?

No. The basis of the work of the immune system is made of millions of lymphocytes prepared to fight millions of antigens at the same time, which at any time come into contact with our skin, nasal or mouth mucous membranes and the interior of the digestive tract. The vaccine carries a very small dose of the antigen, so only a small proportion of the immune system cells are involved. Other cells continue to fight against the microorganisms they encounter, such as influenza viruses.


14. How long does it take for the vaccine to become active? Is it true that I can still be infected with COVID-19 for two weeks?

Comirnata vaccine is fully effective starting from 7 days after the second dose, only partial protection is gained after the first dose. In the case of COVID-19 Vaccine Moderna – this time period is at least 14 days.

COVID-19 Vaccine AstraZeneca may not provide complete protection until at least 15 days after receiving the second dose of vaccine. In turn, the Janssen COVID-19 vaccine may not provide full protection up to 14 days after administration (one dose only). Currently available vaccines may not protect everyone who is vaccinated.

If the contact with an infected person takes place between the first and second dose, it is possible to get sick. If symptoms of infection appear, contact your doctor.


15. Will patients have to wait in the waiting room for a certain amount of time just after the vaccination?

Yes, it is recommended to stay at the healthcare centre for 15 minutes after the vaccination has been administered.


16. Is the vaccination safe for children?

Vaccines have not been tested on people under 16 (Comirnaty) and on people under 18 (COVID-19 Vaccine Moderna, COVID-19 Vaccine Janssen and COVID-19 Vaccine AstraZeneca), therefore their use in children is not recommended (in Poland they are used only in people ≥ 18 years of age).


17. If there are side effects such as muscle pain and fever after the vaccination, how do I know that this is not a COVID-19 infection?

If after the vaccination you have symptoms such as a fever or cough, you should consult your doctor. If the doctor thinks it is likely that you have COVID-19, you will be tested.


18. If I am currently undergoing asymptomatic COVID-19, will the vaccine make me feel worse?

No – and moreover, scientists assume that if the antibodies have already been produced as a result of an infection, receiving the vaccine stimulates the immune system. However, there is currently no data to support this theory.


19. Does the flu vaccine protects against COVID-19?

No – the flu vaccine only protects against the flu virus.


20. Are vaccines used to implant microchips?

The vaccines do not contain any microchips or other harmful elements. The vaccines are medicinal products (just like medicines), so their composition is rigorously controlled in the production of each batch of preparations. This ensures that their composition is identical to what the leaflet says.


21. Will the vaccine give me lifelong immunity?

It is not known – research and observations on the period of post-vaccination immunity are still ongoing. Obviously, pharmaceutical companies and national vaccination organisations will keep the information up to date, and the government will possibly modify the vaccination programme, for instance, by extending it with booster doses (if needed).


22. Can I move around without a face mask after the vaccination?

Medicover patients, just like all adults in Poland, can be vaccinated free of charge as part of vaccination programme financed by the state budget. Anyone who has no contraindications to vaccination will be able to get vaccinated for free. Consequently, vaccinations against COVID-19 will not be part of Medicover packages.


23. Will the vaccination against COVID-19 be part of Medicover packages?

Medicover patients, just like all adults in Poland, can be vaccinated free of charge as part of vaccination programme financed by the state budget. Anyone who has no contraindications to vaccination will be able to get vaccinated for free. Consequently, vaccinations against COVID-19 will not be part of Medicover packages.


24. What will be the price of the vaccination against COVID-19 at Medicover?

The vaccination against COVID-19 is free of charge and financed by the state budget for any citizen who wants to get vaccinated and does not have any contraindications to vaccination.


25. How can I sign up for the COVID-19 vaccination at Medicover?

As soon as the decision to allow Medicover facilities to vaccinate is issued, we will inform you about the process of registrations for the vaccination.


26. When can I get vaccinated against COVID-19?

As soon as the vaccines have been approved by the European Medicines Agency and have reached Poland, the vaccinations will proceed in the following stages:

  • In the so-called stage zero, the vaccines will be given to healthcare professionals (medical and administrative staff), at nursing homes and municipal welfare centres, and to parents of preterm babies hospitalised at the Neonatal Intensive Care Unit.
  • The next stage (stage one) will include:
    • residents of nursing homes, care facilities and other places of stationary residence,
    • persons over 60 years old (starting from the oldest individuals),
    • uniformed services (including military services),
  • In stage two, the vaccinations will be administered to:
    • persons under 60 years of age with chronic diseases increasing the risk of severe course of COVID-19 or persons being diagnosed or treated and hence requiring frequent contact with health care facilities,
    • persons who directly ensure the functioning of the state core activities and are exposed to infection because of their frequent social contacts.
  • Stage three will include:
    • businesspersons and staff working in sectors that have been closed as the consequence of certain restrictions and prohibitions in connection with a state of epidemics,
    • remaining part of adult population.

Vaccination process.


27. What are the side effects of the COVID-19 vaccination?

Clinical trials revealed the occurrence of adverse effects typical of vaccines. The majority of such adverse reactions (side effects) are mild and should not last longer than a few days. Serious adverse post-vaccination reactions occurred rarely. The frequency of severe allergic reaction (anaphylaxis) and hypersensitivity is not known.

The occurrence of systemic adverse post-vaccination reactions was more common after the second dose than after the first of the vaccine, and their course was also more severe. The frequency of adverse post-vaccination reactions of local nature was similar after the administration of both doses.

The frequency of adverse post-vaccination reactions

 

Very common

(may occur in more than 1 out of 10 individuals)

Common

(may occur
in maximum
1 out of 10 individuals)

Uncommon

(may occur
in maximum
1 out of 100 individuals)

Rare

(may occur
in maximum
1 out of 1,000 individuals)

Frequency unknown

(cannot be estimated from the data available)
Comirnaty (Pfizer/ BioNTech)
  • pain, oedema
    at the injection site,
  • fatigue;
  • headache;
  • muscle pain (myalgia);
  • joint pain (arthralgia);
  • chills, fever.
  • reddening
    at the injection site;
  • nausea.
  • enlarged lymph nodes;
  • malaise;
  • pain in the limb;
  • insomnia;
  • itching
    at the injection site;
  • acute peripheral paralysis
    of the facial nerve.
  • acute peripheral paralysis
    of the facial nerve.
 -
COVID-19 Vaccine Moderna
  • enlarged lymph nodes;
  • headache;
  • nausea, vomiting;
  • muscle pain (myalgia) and joint pain (arthralgia);
  • pain at the injection site;
  • fatigue;
  • chills;
  • fever; 
  • oedema at the injection site.
  • rash;
  • reddening at the injection site;
  • nettle rash (urticaria) at the injection site;
  • rash at the injection site.
  • itching
    at the injection site.
  • acute peripheral paralysis
    of the facial nerve;
  • facial oedema.
 -
COVID-19 Vaccine AstraZeneca
  • headache,
  • nausea,
  • muscle pain,
  • joint pain,
  • pain at the injection site,
  • tenderness at the injection site,
  • warmth at the injection site,
  • itching at the injection site,
  • bruising at the injection site,
  • fatigue,
  • feeling unwell,
  • feeling feverish,
  • chills injections,
  • fatigue,
  • feeling unwell,
  • feeling feverish,
  • chills.
  • vomiting,
  • swelling at the injection site,
  • erythema at the injection site,
  • fever (> 38◦C).
  • enlarged lymph nodes,
  • decreased appetite,
  • dizziness,
  • sleepiness,
  • excessive sweating,
  • itching,
  • rash. 
-  -
COVID-19 Vaccine Janssen
  • headache
  • nausea
  • muscle pain
  • fatigue
  • pain at the injection site
  • cough
  • joint pain
  • fever
  • injection site erythema
  • swelling at the injection site
  • shivering
  • trembling
  • sneezing
  • sore throat
  • rash
  • excessive sweating
  • muscle weakness
  • pain in the limbs
  • back pain
  • asthenia (physical and mental exhaustion)
  • feeling unwell
  • hypersensitivity (allergic reactions of the skin and subcutaneous tissues)
  • hives
 ● anaphylaxis

Very rare post-vaccination reactions of COVID-19 Vaccine AstraZeneca and COVID-19 Vaccine Janssen are blood clots with thrombocytopenia.


28. Can I choose the vaccine I will be vaccinated with?

As the vaccination against COVID-19 is free of charge and financed by the state budget, it is not possible to choose the preparation.


29. Is the vaccine safe?

The safety of the vaccine is one of the basic criteria that the European Medicines Agency follows when issuing a decision on its authorisation for use in the European Union. Other criteria include the efficacy and quality of the vaccine as well as an assessment of the benefit-risk balance of the vaccine.

All currently authorized vaccines (Comirnaty, COVID-19 Vaccine Moderna and COVID-19 Vaccine AstraZeneca) mainly cause mild vaccine adverse reactions, i.e. pain at the injection site, fatigue, fever, headache. Most vaccine adverse reactions were mild to moderate in severity and usually resolved within a few days of vaccination.

The safety of Comirnata vaccine and COVID-19 Vaccine Moderna was investigated up to 2 months after the second dose. For COVID-19 Vaccine AstraZeneca, the median follow-up after the second dose was 62 days.

As with any other medicinal product, observations for adverse reactions for all vaccines are continued.


30. Do I have to get vaccinated?

For the sake of your health, we recommend to do so.


31. If the vaccination causes any serious complications, will I get any compensation?

The government has announced that a special fund was set up. The fund will be used to pay compensation to individuals who have suffered adverse vaccination reactions.


32. How did it happen that the vaccine was developed so quickly?

First of all, the technology that many scientists have been working on for years has been used – and the research on the use of mRNAs in vaccines has been going on for at least several years. One of the latest such vaccines on which scientists worked was the vaccine against the Zika virus. Research is also under way on such a vaccine against influenza.

Moreover, a great deal of work, research and legislation has been carried out at the same time, and agencies responsible for authorising medicines on the market (such as the European EMA and the American FDA) have allowed for the documentation to be delivered in batches. In addition, many official deadlines for submitting the relevant documents or issuing opinions have been reduced.

Although the whole process has been sped up, however, all the standard procedures relating to the quality, safety and efficacy of the vaccine have not been ignored.


33. Will a doctor examine me before the vaccination?

Yes, before the vaccination the doctor carries out a qualification. During the qualification please inform the doctor if you:

  • suffer from any allergies,
  • have a fever,
  • have a blood clotting disorder and take anticoagulants,
  • have a reduced immunity or you are taking medications that affect your immune system,
  • are pregnant (or plan to get pregnant),
  • are breastfeeding,
  • were vaccinated with another vaccine against COVID-19.

34. Do any tests need to be done before the vaccination?

No, the approach to vaccination does not require special preparation or testing. To get vaccinated, you need a qualification from a doctor.


35. What is the vaccine administration like?

The first step is to qualify for the vaccination. Your doctor will qualify you for the vaccination. The nurse will then give you the vaccine – as an injection into your shoulder muscle. The second dose will be administered in the same way 21 days after the first dose.

There are several doses of the vaccine in one vial, so the nurse will take the right amount of liquid into a sterile disposable syringe, and then will proceed to make an injection.


36. Is a referral required for the vaccination? 

The vaccination process will be based on an invitation (an e-referral document) that is valid for 60 days from its issue date. E-referrals will be generated automatically in the P1 system (Electronic Platform for Collection, Analysis and Sharing of Digital Medical Records) in batches to make sure they are consistent with the order of vaccinations (for specific age groups and specific professionals, etc.). Moreover, doctors will be able to issue individual e-referrals for patients (e.g. for an individual who does not have a PESEL number, or for a person who could not be vaccinated during the period of validity of their first e-referral).


37. Will vaccinations against COVID-19 be available at Medicover?

Yes, Medicover will participate in the process of vaccinations against COVID-19. The National Health Fund approved all the facilities we have submitted to the programme – except for the Tarchomin Medicover Centre in Warsaw. The vaccinations will be carried out at our other own centres in Warsaw.


The material was prepared on the basis of sources valid as at 16 February 2021. The information will be updated.

Vaccination Program at workplaces

Dear All,

yesterday, on 26 April 2021 at 11:00, the Chief of the Chancellery of the Prime Minister, Michał Dworczyk, announced that the registration for employers interested in carrying out the COVID-19 vaccination campaign will be launched on 04 May 2021.

According to that announcement, a special application form for companies should be published on the website of the Government Centre for Security at on 04 May 2021.

The final guidelines for the vaccinations at the workplace have also been determined. To check the current guidelines, please click here.

The key information is as follows:

  1. Before filling in the application form on the website of the Government Centre for Security, the employer should already have a confirmed Medical Treatment Provider (Polish abbreviation: PWDL, Podmiot Wykonujący Działalność Leczniczą) reported to the National Health Fund (NFZ) as the Vaccination Point that will carry out the vaccinations.
  2. One workplace can submit, at the same time, maximum one application in which it specifies the data of the cooperating Medical Treatment Provider
    and the number of registered individuals: minimum 300 persons (including the members of the families of employees and co-workers).
  3. Submission of the application using the government form means that the workplace is ready to vaccinate the registered individuals in cooperation with the selected Medical Treatment Provider. The vaccinations may take place after the logistics (location and preparation for vaccinations) has been discussed and agreed with the Medical Treatment Provider.
  4. The beginning of vaccinations at workplaces is subject to availability of vaccines.
  5. The order of vaccinations will be determined by the Government Centre for Security on the first-come-first-served basis to the (on the basis of the moment when the form has been correctly filled out by the employer) as well as the availability of vaccines. The dates for the launch of vaccinations in each location will be specified by the Government Strategic Reserve Agency (RARS).

Consequently, today at 11.00 a.m. we will publish an application form at through which you will be able to register your need for vaccinations to be carried out by Medicover.

We will analyse the applications on an ongoing basis. Please note that only upon confirming the acceptance of your application for vaccinations to be administered by Medicover can you complete the application form on the website of the Government Centre for Security.

 

Date added 27.04.2021

Check the previous information:

17.04.2021 - The draft guidelines for organisation of vaccinations at workplaces

08.04.2021 - COVID-19 Vaccination Program at workplaces - update

01.04.2021 - COVID-19 Vaccination Program at workplaces